MBX Biosciences, Inc. MBX Share Repurchase Liability
Share Repurchase Liability at other companies
Other financials
Where this comes from
Reported directly by MBX Biosciences, Inc. in its filing.
Tagged under the XBRL concept mbx:ShareRepurchaseLiability.
The official record: MBX Biosciences, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about MBX Biosciences, Inc.'s share repurchase liability.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is MBX Biosciences, Inc.'s share repurchase liability?
- MBX Biosciences, Inc. (MBX) reported share repurchase liability of $1K in Q1 2026.
- How has MBX Biosciences, Inc.'s share repurchase liability changed year-over-year?
- MBX Biosciences, Inc.'s share repurchase liability decreased by 95.7% year-over-year, from $23K to $1K.
- What is the long-term trend for MBX Biosciences, Inc.'s share repurchase liability?
- Over 2 years (2023 to 2025), MBX Biosciences, Inc.'s share repurchase liability has grown at a -89.8% compound annual growth rate (CAGR), from $194K to $2K.
- What does share repurchase liability mean?
- This metric represents the financial obligation arising from commitments to buy back company shares from the open market or specific shareholders. It reflects the total value of authorized or contracted repurchases that have not yet been settled or paid out. Monitoring this liability is essential for understanding future cash outflows related to capital allocation strategies and potential impacts on shareholder equity.